Medical Marijuana, Inc. Subsidiary Kannaway ® Supports European Industrial Hemp Association in Opinion Letter on Legal Status of CBD and Hemp

SAN DIEGO, Aug. 04, 2020 (WORLD NEWSWIRE)– through NEWMEDIAWIRE– Medical Cannabis, Inc.( OTC: MJNA) (the “Company”), the first-ever openly traded cannabis business in the United States that released the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway ® is proud to support the European Industrial Hemp Association (EIHA) in its recent opinion letter to the European Commission on the legal status of cannabidiol (CBD) and hemp.

EIHA’s letter was composed in reaction to the European Commission’s decision to suspend all applications for hemp extracts and natural cannabinoids under the European Union’s Novel Food rules and likewise consider under a “initial conclusion” that extracts from the flowering and fruiting tops of the hemp plant ought to be thought about a drug under the United Nations Single Convention on Narcotic Drugs of1961 EIHA explains that the choice is “not based upon the latest scientific literature nor influenced by the present debate at the United Nations level.”

EIHA believes that industrial hemp and its downstream products are not narcotic or psychotropic drugs. Hemp is excused from the scope of the United Nations Single Convention of 1961, which features a clear difference in between cannabis varieties grown for the production of drugs and exempting marijuana grown for any other function (with low levels of THC).

” Hemp has been a food source for centuries and for decades the EU has specified that hemp extracts are not novel. It looks like a political relocate to now try to alter its legal status,” said Kannaway ® Handling Director of International Janne Heimonen. “There is fantastic consumer demand for items and hemp farming supports the EU’s enthusiastic sustainability objectives. We are fully devoted to assisting the industry keep supplying customers the products they need.”

Kannaway ® has led the CBD industry in Europe because2018 In December 2019, Kannaway ® executives spoke in the European Parliament at an unique event on “The State of Hemp in Europe” about how to improve the European hemp market for all of its applications consisting of CBD items.

” Kannaway has pioneered the hemp CBD industry in Europe and prepares to continue to grow its robust market there,” said Kannaway ® CEO Blake Schroeder. “Our portfolio of Business has dealt with government leaders around the world to make sure that people have legal access to CBD and we will do the same in Europe.”

For more information about Kannaway ®, please go to http://www.kannaway.com

About Kannaway

Kannaway ® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical items. Kannaway ® presently hosts weekly online sales meetings and conferences across the United States, using unique insight and chance to sales professionals who are desirous of ending up being effective leaders in the sale and marketing of hemp-based botanical items.

About Medical Marijuana, Inc.
We are a business of firsts ® Medical Cannabis, Inc. ( MJNA) is a cannabis business with 3 distinct business systems in the non-psychoactive cannabinoid area: a global portfolio of cannabinoid-based nutraceutical brand names led by Kannaway ® and HempMeds ® ; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis items stemmed from commercial hemp; and a cannabinoid-based scientific research and botanical drug advancement sector led by its pharmaceutical investment firm and partners including AXIM ® Biotechnologies, Inc and Kannalife, Inc Medical Marijuana, Inc. was named a leading CBD manufacturer by CNBC Medical Marijuana, Inc. was likewise the very first company to receive historical import permits for CBD items from the federal governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the advancement of worldwide markets. The business’s flagship product Genuine Scientific Hemp Oil has been utilized in a number of successful clinical studies throughout Mexico and Brazil to comprehend its safety and efficacy.

Medical Marijuana, Inc.’s headquarters remains in San Diego, California, and extra information is readily available at OTCMarkets.com or by checking out www.medicalmarijuanainc.com To see Medical Marijuana, Inc.’s corporate video, click here

Shareholders and customers are also motivated to buy CBD oil and other items at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER
This news release may include certain forward-looking declarations and info, as defined within the meaning of Section 27 A of the Securities Act of 1933 and Area 21 E of the Securities Exchange Act of 1934, and undergoes the Safe Harbor developed by those sections. This product includes statements about expected future events and/or monetary results that are positive in nature and topic to risks and unpredictabilities. Such forward-looking statements by meaning include risks, unpredictabilities and other elements, which may cause the actual results, efficiency or accomplishments of Medical Marijuana, Inc. to be materially various from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These declarations have not been assessed by the Food and Drug Administration. This product is not meant to diagnose, deal with, cure, or avoid any disease.

LEGAL DISCLOSURE
Medical Cannabis, Inc. does not sell or distribute any products that remain in infraction of the United States Controlled Substances Act.

CONTACT:
Public Relations Contact:
Andrew Hard
President
CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com

Investor Relations Contact:
P. (858) 283-4016
[email protected]